Cargando…
Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
BACKGROUND: The rapidly expanding arsenal of chemotherapeutic agents approved in the past 5 years represents significant progress in the field. However, this poses a challenge for oncologists to choose which drug or combination of drugs is best for any individual. Because only a fraction of patients...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097425/ https://www.ncbi.nlm.nih.gov/pubmed/27814715 http://dx.doi.org/10.1186/s12885-016-2886-9 |